@article{eliadis:hal-01282335,
TITLE = {SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer},
AUTHOR = {Eliadis, Paul and Isaacs, Richard and Price, David and Moeslein, Fred and Taieb, Julien and Bower, Geoff and Gebski, Val and van Buskirk, Mark and Cade, David N. and Thurston, Kenneth and Gibbs, Peter and Hazel, Guy A. Van and Heinemann, Volker and Sharma, Navesh K. and Findlay, Michael P. N. and Ricke, Jens and Peeters, Marc and Perez, David and Robinson, Bridget A. and Strickland, Andrew H. and Ferguson, Tom and Rodrigez, Javier and Kr{\"o}ning, Hendrik and Wolf, Ido and Ganju, Vinod and Walpole, Euan and Boucher, Eveline and Tichler, Thomas and Shacham-Shmueli, Einat and Powell, Alex},
URL = {https://univ-rennes.hal.science/hal-01282335},
JOURNAL = {Journal of Clinical Oncology},
PUBLISHER = {American Society of Clinical Oncology},
VOLUME = {34},
NUMBER = {15},
PAGES = {1723-31},
YEAR = {2016},
MONTH = May, DOI = {10.1200/JCO.2015.66.1181},
HAL_ID = {hal-01282335},
HAL_VERSION = {v1},
}